| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 21 |
| 1 | CYCLOPHOSPHAMIDE | 19 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 19 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 19 |
| 4 | METHOTREXATE SODIUM | 19 |
| 5 | PREDNISONE | 19 |
| 6 | METHOTREXATE | 18 |
| 7 | DEXAMETHASONE | 17 |
| 8 | DEXAMETHASONE 1.5 MG | 17 |
| 9 | UPADACITINIB | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TINIDAZOLE | 1 | 0.0023 |
| 1 | BARICITINIB | 6 | 0.0020 |
| 2 | INFLIXIMAB-AXXQ | 2 | 0.0017 |
| 3 | DEXRAZOXANE FOR INJECTION | 1 | 0.0011 |
| 4 | CEDAZURIDINE AND DECITABINE | 1 | 0.0010 |
| 5 | BETAINE | 1 | 0.0010 |
| 6 | RILONACEPT | 1 | 0.0009 |
| 7 | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | 2 | 0.0008 |
| 8 | GLUTATHIONE | 1 | 0.0006 |
| 9 | EMPAGLIFLOZIN AND LINAGLIPTIN | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 42 |
| 1 | Alkylating Drug [EPC] | 23 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 19 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 19 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| 5 | Microtubule Inhibitor [EPC] | 14 |
| 6 | Janus Kinase Inhibitor [EPC] | 13 |
| 7 | Vitamin C [EPC] | 13 |
| 8 | Atypical Antipsychotic [EPC] | 12 |
| 9 | Integrin Receptor Antagonist [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Methylating Agent [EPC] | 1 | 0.0010 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 2 | Integrin Receptor Antagonist [EPC] | 12 | 0.0001 |
| 3 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Nitroimidazole Antimicrobial [EPC] | 9 | 0.0001 |
| 5 | Vitamin K [EPC] | 1 | 0.0001 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 8 | 0.0001 |
| 7 | Alkylating Drug [EPC] | 23 | 0.0001 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 9 | Sulfone [EPC] | 1 | 0.0001 |